Previous attempts to test the hypothesis that laboratory selection of isogenetic populations can produce test organisms with a significantly increased mean tolerance to toxic substances have failed. One possible explanation for such failure is that the tolerance of laboratory populations is largely constrained by their origins (were the source populations composed of tolerant genotypes?). To address this question, among- and within-population variability in stress tolerance was assessed by calculating the variance in individual fitness and longevity across a cadmium gradient (0-10 microg/L). The study employed Daphnia magna clones from four geographically separate European populations. Results revealed significant differences in tolerance to lethal levels of toxic stress among populations. The distribution of tolerances within two of the studied populations showed high amounts of genetic variation in tolerance. Genetic relationships between tolerance traits and life history performance under nonstressful environments differed among the studied populations. One population showed significant but low costs associated with tolerance, whereas no costs were associated with tolerance in the other population. These results suggest that laboratory selection will favor individuals with high fitness or reproductive performance under optimal laboratory conditions resulting in laboratory populations with similar or lower tolerance to toxic stress than their original field populations. Given that populations can exhibit high levels of genetic variability in tolerance to toxic stress, minimizing genetic diversity in toxicity tests will increase the uncertainty attendant in extrapolating from the lab to the field.
Download full-text PDF |
Source |
---|
Pest Manag Sci
January 2025
College of Resources and Environment, Henan Institute of Science and Technology, Xinxiang, China.
Background: Fomesafen is a selective herbicide widely used to control post-emergent broad-leaf weeds in soybean and peanut fields. Because of its persistent nature in soil, it can suppress subsequent crops, including wheat. There is limited information focusing on methods of protecting wheat from fomesafen injury by soil residue.
View Article and Find Full Text PDFJ Transl Med
January 2025
Department of Medical Oncology, Division of Life Sciences and Medicine, The First Affiliated Hospital of USTC, University of Science and Technology of China, Anhui Provincial Cancer Hospital, Hefei, 230031, Anhui, China.
Background: Agonistic monoclonal antibodies targeting 4-1BB/CD137 have shown preclinical promise, but their clinical development has been limited by severe liver toxicity or limited efficacy. Therefore, a safe and efficient immunostimulatory molecule is urgently needed for cancer immunotherapy.
Methods: A novel anti-MSLN×4-1BB bispecific antibody (bsAb) was generated via antibody engineering, and its affinity and activity were detected via enzyme-linked immunosorbent assay (ELISA), flow cytometry, and T-cell activation and luciferase reporter assays.
Mol Biotechnol
January 2025
Noncommunicable Disease Research Center, Jahrom University of Medical Sciences, Jahrom, Iran.
Despite significant advancements in gene delivery and CRISPR technology, several challenges remain. Chief among these are overcoming serum inhibition and achieving high transfection efficiency with minimal cytotoxicity. To address these issues, there is a need for novel vectors that exhibit lower toxicity, maintain stability in serum-rich environments, and effectively deliver plasmids of various sizes across diverse cell types.
View Article and Find Full Text PDFEnviron Pollut
January 2025
College of Grassland Science and Technology, Sichuan Agricultural University, Chengdu 611130, China.
Lead (Pb), one of the most ubiquitous and harmful contaminants of farmland, seriously threatens soil health and food security. Silicon nanoparticles (SiNPs) have potential applications in soil remediation and phytoremediation. Yet, how SiNPs influence plant growth under Pb stress remains poorly understood.
View Article and Find Full Text PDFAnn Oncol
January 2025
David Geffen School of Medicine at UCLA, Los Angeles, CA, USA. Electronic address:
Background: Osimertinib is the standard first-line treatment for advanced epidermal growth factor receptor (EGFR)-mutated NSCLC. However, treatment resistance is inevitable and increased c-Met protein expression correlates with resistance. Telisotuzumab vedotin (Teliso-V) is an antibody-drug conjugate that targets c-Met protein overexpression.
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!